Showing results (271-280 of 324) with videos related to

Sort By:
Pageof 33
BMJ Open|January 19, 2021
International Physical Activity and Built Environment Study of adolescents: IPEN Adolescent design, protocol and measuresKelli L Cain, Jo Salmon, Terry L Conway, et al.
International Journal of Cancer|November 4, 2025
Toxicity-related immunotherapy discontinuation and outcome in patients with advanced renal cell carcinoma treated with immune-based combinations (ARON-1 study)Javier Molina-Cerrillo, Giandomenico Roviello, Maria T Bourlon, et al.
European Journal of Endocrinology|August 14, 2025
External validation of the S-GRAS score for predicting recurrence in patients with adrenocortical carcinoma: implications for adjuvant mitotane therapyPaula Jimenez-Fonseca, Cristina Álvarez-Escola, Inmaculada Ballester Navarro, et al.
The Oncologist|February 25, 2025
Nutritional status and quality of life of patients with advanced gastroenteropancreatic neuroendocrine neoplasms in Spain: the NUTRIGETNE (GETNE-S2109) studyMaribel Del Olmo-García, Lorena Hernandez-Rienda, Rocio Garcia-Carbonero, et al.
Clinical and Experimental Medicine|November 2, 2023
Bone targeting agents, but not radiation therapy, improves survival in patients with bone metastases from advanced urothelial carcinoma receiving pembrolizumab: results from the ARON-2 studyMatteo Santoni, Francesco Massari, Hideki Takeshita, et al.
Frontiers in Immunology|May 6, 2026
Real-world incidence of G3-G4 adverse events in patients with advanced renal cell carcinoma receiving immune-combinations (ARON-1)Evelyn L Beas-Lozano, Sarah Scagliarini, Paola I Valdez-Sandoval, et al.
The Oncologist|May 25, 2026
Real-World outcomes and prognostic factors in anaplastic thyroid cancer: Evidence from the REGETNE-Thyroid cohortPau Mascaró-Baselga, José Miguel Rodellar Sanz, Tiago Nunes, et al.
Frontiers in Immunology|March 12, 2026
Liver metastases in advanced urothelial carcinoma (ARON-2): do pembrolizumab and avelumab make a difference in a poor-prognosis scenario?Linda Cerbone, Giandomenico Roviello, Fabio Calabrò, et al.
Cancer Immunology, Immunotherapy : CII|June 4, 2024
Sex and survival outcomes in patients with renal cell carcinoma receiving first-line immune-based combinationsLorena Incorvaia, Fernando Sabino Marques Monteiro, Francesco Massari, et al.
The Journal of Allergy and Clinical Immunology. Global|July 6, 2026
Genetic variants associated with clinical characteristics and atopies in eosinophilic esophagitisLeticia Rodríguez-Alcolado, Marcos Navares-Gómez, Sergio Casabona-Francés, et al.
Pageof 33